The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is urging industry stakeholders worldwide to focus on science and not geography, in a call for greater global collaboration
Cyrus Biotechnology, a Seattle-based biotech software company has announced the release of a novel antibody structure prediction software tool as part of its Cyrus Bench platform
Certara has announced that it will partner with the US Centers for Disease Control & Prevention (CDC) to strengthen the Agency’s death investigation and surveillance systems
Oxford Gene Technology (OGT), has announced that it is expanding its Cytocell operations with a move to a new facility in Cambridge, UK
Certara is aiming to increase the use of Model-informed Precision Dosing (MIPD) to help make individualised dosing more prevalent in clinics
The Pistoia Alliance has announced that it is launching the next phase of its blockchain project which aims to identify potential applications for the use of blockchain in the life sciences
Dotmatics and TetraScience recently announced a strategic partnership to bring R&D labs an improved relationship with their scientific data.
Kaia Health, has announced it has raised $10 million in a Series A round led by Balderton Capital to tackle some of the world’s most urgent health challenges, including a range of chronic conditions
A new report from the Pistoia Alliance finds that multi-disciplinary innovation, the implementation of new technologies, new approaches to research, the digitisation of R&D and healthcare, and academic contributions to biologics drug R&D are all key trends in the life sciences industry.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
